Use of pteridines and / or purines or a xanthine oxidase inhibitor for the manufacture of a medicament for the treatment of degenerative diseases of the retina genetically conditioned.

摘要

Pteridine UTILIZATION AND / OR BIOCHEMICAL PRECURSORS xanthine DELAYED FOR TREATING RETINAL DISEASES ORIGINATED GENETICALLY DEGENERATIVE, ESPECIALLY RETINOPATHY PIGMENTOSA (RP) and manufacture of a medicament accordingly.